The findings of an in vitro experiment demonstrated that PTX-siRNAVEGF-NPs can greatly reduce the level of VEGF mRNA expression, suppress the proliferation of breast cancer 4T1 cells, and increase the apoptosis of breast cancer 4T1 cells. Here, VEGFA is linked to breast carcinoma.